Answers are grounded in this paper and cite their sources.
Bacterial-infected wound healing is severely impeded by the complex, self-perpetuating wound microenvironment (WME) characterized by biofilm infection, hypoxia, excessive oxidative stress, and persistent inflammation. Effective repair demands smart therapeutic interventions capable of autonomously adapting to the evolving pathological landscape-a feature absent in most current treatments. To address this critical need, a novel bimetallic nanozyme (MCCN) is engineered by integrating manganese (III) porphyrin into cobalt-doped mesoporous carbon-nitrogen nanocubes, serving as a smart modulator for autonomous WME remodeling. The MCCN exhibits oxidase (OXD), superoxide dismutase (SOD), and catalase (CAT)-like activities, and enables pH-responsive catalytic switching. In acidic biofilms, it initiates a self-sustaining OXD/SOD/CAT catalytic cycle that continuously generates singlet oxygen for biofilm eradication. As infection resolves and pH neutralizes, it autonomously switches to a SOD/CAT cascade that scavenges reactive oxygen species and supplies oxygen, alleviating oxidative stress and hypoxia while promoting tissue regeneration. The data demonstrate that the MCCN integrates potent antibacterial, antioxidant, anti-inflammatory, and pro-angiogenic functions, making it an efficient and safe nanomedicine for treating infected wounds via a WME self-adaptive intervention pathway. Our work establishes a groundbreaking "smart catalytic" paradigm for dynamic pathological microenvironment remodeling, offering a promising therapeutic avenue for refractory wounds and other microenvironment-associated diseases.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: